Vineti is a pioneering cell and gene therapy software and analytics company.
About Vineti Stock
Vineti is the first commercial cloud-based platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE and the Mayo Clinic to solve the key challenges patients, medical providers, biopharmaceutical companies and regulators face in the delivery and commercialization of 21st century medicine. The Vineti platform integrates logistics, manufacturing and clinical data to improve product performance overall. Caregivers and pharmaceutical pioneers are empowered to help more patients more effectively and safely, treatments are better understood and improved over time, and most importantly, there’s an opportunity to provide greater health outcomes—and cures—to patients in need.
Chief Strategy Officer
Heidi M. Hagen
Chief Science Officer
SVP Finance & Operations
CO-Founder and Chief Executive Officer
VP, Software Products
Co-founder & Director of Marketing
GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market
TechCrunch - Jun, 20 2017